skip to main | skip to sidebar

biosink

7.24.2007

Doctor Unable To Hide Excitement From Patient With Rare Disease | The Onion - America's Finest News Source

Doctor Unable To Hide Excitement From Patient With Rare Disease | The Onion - America's Finest News Source: "Doctor Unable To Hide Excitement From Patient With Rare Disease"
Posted by <> at 01:13
Newer Post Older Post Home

Blog Archive

  • ►  2013 (14)
    • ►  05/05 - 05/12 (1)
    • ►  04/07 - 04/14 (9)
    • ►  03/31 - 04/07 (1)
    • ►  03/10 - 03/17 (3)
  • ►  2010 (4)
    • ►  06/13 - 06/20 (1)
    • ►  01/31 - 02/07 (2)
    • ►  01/10 - 01/17 (1)
  • ►  2009 (22)
    • ►  09/20 - 09/27 (2)
    • ►  09/06 - 09/13 (1)
    • ►  08/09 - 08/16 (1)
    • ►  08/02 - 08/09 (1)
    • ►  07/12 - 07/19 (1)
    • ►  05/10 - 05/17 (2)
    • ►  04/19 - 04/26 (5)
    • ►  04/12 - 04/19 (1)
    • ►  04/05 - 04/12 (7)
    • ►  03/01 - 03/08 (1)
  • ►  2008 (290)
    • ►  12/28 - 01/04 (2)
    • ►  12/21 - 12/28 (4)
    • ►  12/14 - 12/21 (2)
    • ►  11/23 - 11/30 (1)
    • ►  10/26 - 11/02 (5)
    • ►  10/19 - 10/26 (5)
    • ►  10/12 - 10/19 (55)
    • ►  10/05 - 10/12 (1)
    • ►  09/28 - 10/05 (1)
    • ►  09/21 - 09/28 (45)
    • ►  09/14 - 09/21 (3)
    • ►  08/31 - 09/07 (5)
    • ►  08/24 - 08/31 (20)
    • ►  08/17 - 08/24 (3)
    • ►  08/10 - 08/17 (1)
    • ►  08/03 - 08/10 (3)
    • ►  07/13 - 07/20 (1)
    • ►  07/06 - 07/13 (2)
    • ►  06/29 - 07/06 (13)
    • ►  06/15 - 06/22 (2)
    • ►  06/08 - 06/15 (2)
    • ►  06/01 - 06/08 (2)
    • ►  05/25 - 06/01 (7)
    • ►  05/18 - 05/25 (7)
    • ►  05/11 - 05/18 (1)
    • ►  04/27 - 05/04 (9)
    • ►  04/20 - 04/27 (22)
    • ►  04/13 - 04/20 (11)
    • ►  04/06 - 04/13 (20)
    • ►  03/30 - 04/06 (4)
    • ►  03/23 - 03/30 (1)
    • ►  03/16 - 03/23 (1)
    • ►  03/09 - 03/16 (1)
    • ►  02/24 - 03/02 (3)
    • ►  02/17 - 02/24 (10)
    • ►  02/10 - 02/17 (5)
    • ►  02/03 - 02/10 (2)
    • ►  01/27 - 02/03 (3)
    • ►  01/13 - 01/20 (4)
    • ►  01/06 - 01/13 (1)
  • ▼  2007 (1218)
    • ►  12/16 - 12/23 (4)
    • ►  12/02 - 12/09 (5)
    • ►  11/25 - 12/02 (4)
    • ►  11/18 - 11/25 (22)
    • ►  11/11 - 11/18 (31)
    • ►  11/04 - 11/11 (10)
    • ►  10/28 - 11/04 (4)
    • ►  10/21 - 10/28 (15)
    • ►  10/14 - 10/21 (31)
    • ►  10/07 - 10/14 (85)
    • ►  09/30 - 10/07 (129)
    • ►  09/23 - 09/30 (23)
    • ►  09/16 - 09/23 (98)
    • ►  09/09 - 09/16 (116)
    • ►  09/02 - 09/09 (52)
    • ►  08/26 - 09/02 (57)
    • ►  08/19 - 08/26 (52)
    • ►  07/29 - 08/05 (40)
    • ▼  07/22 - 07/29 (173)
      • Patent Docs: Biosimilars 2007 Conference
      • Patent Docs: Ranbaxy and GlaxoSmithKline Settle Va...
      • BioCryst Initiates Phase II Clinical Trial to Eval...
      • Sector Glance: Biotechnology - Forbes.com
      • Patent Law Jobs by Patently-O: Patent Counsel - Me...
      • Xconomy � Blog Archive � Reeves to Menino: Cambrid...
      • FDA Reviewer Rips Nissens (DrugWonks)
      • Health Blog : Merck's Vioxx Warrior Gets Promoted
      • Patent Prospector: Scratch & Sniff
      • Have I Been Misreading the FDA? (DrugWonks)
      • Sector Glance: Biotechnology - Forbes.com
      • Neogen Announces 3-for-2 Stock Split
      • Health Blog : FDA Committee Won't Consider Controv...
      • The Volokh Conspiracy - Lawsuit Challenging Qualif...
      • : "NEW DELHI: Riding on the success of Bt cotton, ...
      • Biolex Therapeutics Announces Positive Phase 2a Re...
      • Threshold Pharmaceuticals Initiates Phase 1 Clinic...
      • EntreMed Commences Leukemia Clinical Trial for MKC...
      • Peter Zura's 271 Patent Blog: Manufacturing and La...
      • FDA Drug Approval Statistics
      • Patent Prospector: Laboring over Patent Reform
      • Biotech Blog � Expanding the bandwidth of life sci...
      • Fresh from the FDA Dockets (DrugWonks)
      • Patent Law Blog (Patently-O): No Revival For "Unin...
      • Aspreva cuts a quarter of its jobs as it refocuses...
      • ADA Applauds Legislators for 'Meth Mouth' Bills
      • Cell Therapeutics inks deal to buy cancer drug dev...
      • Pfizer, Hydra strike $195M pain pact - FierceBiote...
      • Biotech CEOs face rising fury of angry investors -...
      • Faster, Easier Quantification of Secreted IgG Anti...
      • New compounds in works for tuberculosis - FierceBi...
      • Scientists plot first moves for Project Checkmate ...
      • Synthetic biology spawns fresh approach to antibio...
      • ALSO NOTED: Fat cells could be used to replace sil...
      • Reduced insulin signaling may halt aging, disease ...
      • Patch to replace heart transplants? - FierceBioRes...
      • ALSO NOTED: Geron faces critics' wrath;New diagnos...
      • Health Blog : An Ugly Saga of Politics and AIDS Wi...
      • Health Blog : Drug Companies Seize Tax Break, Cut ...
      • Health Blog : Japanese Takeout: Drug Making
      • ALSO NOTED: Advanced Magnetics touts Phase III dat...
      • Press Release: BioXell To Regain Rights To TREM Pl...
      • Health Blog : FDA Delays Decision on Wyeth Menopau...
      • Biosecurity expert points to threat of smallpox at...
      • Venter's latest revelation could save the world - ...
      • Health Blog : Goldman Gets Into Hospital Software
      • Cell Therapeutics, Inc. Announces $20.25 Million O...
      • Orange Book Blog: Federal Circuit Affirms Invalidi...
      • Health Blog : Insurers Put Money Behind Doctor Rat...
      • Evogene and CIRAD Expand Their Cotton Collaboration
      • SignOnSanDiego.com > News > Business -- Amylin rep...
      • US presses ahead with patent reforms - ZDNet UK
      • Sector Snap: Drug Companies - Forbes.com
      • Patent Docs: Organon and MRC Technology to Collabo...
      • Patent Docs: USPTO News: Patent Office Sends KSR T...
      • Patent Docs: USPTO News: New Continuation and Clai...
      • FDA Oncologic Drugs Advisory Committee Recommends ...
      • MaRS Blog - Innovation and Commercialization in Ca...
      • Patent Prospector: Dealing with KSR
      • Biotech Definitions: "Biotech DefinitionsBIO-INFOM...
      • Biotechnology in Texas
      • Protalex Announces Preliminary Results in Phase I ...
      • The Fire of Genius � A New Essay
      • Orexigen claims success in weight-loss trial - Fie...
      • Big Pharma brings home the cash, slices payroll - ...
      • New hope for cross-species transplantation - Fierc...
      • Controlling brain protein may modulate stress, moo...
      • Biotech pioneer bets a billion on Alzheimer's prog...
      • FDA demands more data on Wyeth's Pristiq - FierceB...
      • OilOnline - The Original Online Source for the Oil...
      • Alzheimer's Drug Discovery Foundation Invites Scie...
      • Fourth ACTEMRA(TM) (tocilizumab) Phase III Study D...
      • IPOX Schuster's New China IPO Index Focused On 'A'...
      • PharmaLive: DSM Biologics and Crucell Announce PER...
      • From the Sequencer to the Drugstore?. In the Pipel...
      • Patent Prospector: USPTO Rule Changes
      • Health Blog : The Science of Peppers and Pain
      • Pharma Marketing Blog: Why Do DTC Ads - "Viva Viag...
      • Health Blog : Glaxo's Earnings Steady, Despite Ava...
      • Patent Prospector: Silk Purse from a Sow's Ear
      • News: Arena Pharmaceuticals Initiates Phase 1 Clin...
      • A Farewell to Tin. In the Pipeline:
      • ScienceDaily: Study Urges Compensation-based Appro...
      • Health Blog : Building Family-Friendly ICUs
      • Want To Live Longer? Take New Drugs (DrugWonks)
      • Bioethics Crisis in China
      • News: Scientists Find Compound that Targets Therap...
      • Biotech Blog � Drug reimportation: Where are the d...
      • QLT announces FDA filing and review of Aczone(TM) ...
      • EpiCept Announces Phase III Study of EpiCept(TM) N...
      • GeekPress
      • SPOTLIGHT: Targeted Genetics study on hold - Fierc...
      • Anticipate This! EP-Oh! (Information about the Eur...
      • Patent Docs: Mergers and Acquisitions Are Preferre...
      • The IN VIVO Blog
      • Health Blog : Lab Values Predict Mortality for Hos...
      • Genstar inks $744M deal to buy PRA International -...
      • WuXi PharmaTech files $120M IPO on NYSE - FierceBi...
      • China pushes drug development as R&D soars - Fierc...
      • Merck snares NovaCardia in $350M buyout - FierceBi...
    • ►  07/15 - 07/22 (24)
    • ►  07/08 - 07/15 (10)
    • ►  05/06 - 05/13 (7)
    • ►  04/29 - 05/06 (76)
    • ►  04/22 - 04/29 (150)